Hemex Health

Portland, United States Founded: 2016 • Age: 10 yrs
Platform providing care devices for the detection of tropical diseases

About Hemex Health

Hemex Health is a Healthcare company based in Portland (United States) founded in 2016. Platform providing care devices for the detection of tropical diseases. Hemex Health has raised $6.24 million across 16 funding rounds from investors including NIH, The Indus Entrepreneurs and CTIP. The company has 1 employees. Its chief executive, as recorded, is Patti White. Its Indian entity Hemexdx Private Limited reported revenue of β‚Ή30.36 Cr. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Hemoglobinopathies. Its competitors include BioMedomics, Silver Lake Research Corporation and Halcyon Biomedical; 1 of its 3 listed competitors has raised funding.

Company details

Hemex Health was founded in 2016 in Portland, United States, within the health technology sector. Medical devices for diagnosing tropical diseases are developed through the platform. Two products are currently under development: a magneto-optical device used for rapid detection of all malaria species and HemeChip, a miniaturized form of cellulose acetate electrophoresis applied in sickle cell anemia diagnosis. Operations focus on point-of-care solutions for global health challenges.

  • Headquarters Portland, United States
  • Employees 1
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website hemexhealth.com
  • Legal Name Hemexdx Private Limited
  • Date of Incorporation 15 May, 2018
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹30.36 Cr

    FY 2025 · +16% YoY

  • Indian entity net loss
    -₹5.45 Cr

    FY 2025 · -18% margin

  • Indian entity EBITDA
    -₹5.35 Cr

    FY 2025 · -18% margin

  • Total Equity Funding
    $6.24M (USD)

    in 16 rounds

  • Latest Funding Round
    $332.12K (USD), Grant

    Sep 2024

  • Investors
    NIH

    & 10 more

  • Employee Count
    1

Funding Insights of Hemex Health

Hemex Health has successfully raised a total of $6.24M across 16 strategic funding rounds. The most recent funding activity was a Grant round of $332.12 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.24M
  • Total Rounds 16
  • Last Round Grant β€” $332,122
  • First Round $50,000

    (Oct 2016)

  • Investors Count 11

Latest 10 of 16 funding rounds of Hemex Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$332,122Grant––
Jan 2024$295,920Grant––
Mar 2023$3MGrant––
Mar 2022Grant––
Apr 2021$256,580Grant––
Oct 2020$100,000Grant––
Aug 2020$1.67MGrant––
Apr 2020$225,000Grant––
Sep 2018$3.72MGrant––
Aug 2018$1.96MGrant––
Valuation history

11 investors in total: 11 institutional.

Investors in Hemex Health

Hemex Health has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, The Indus Entrepreneurs and CTIP.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Provider of angel network firm
1992tie.orgSunnyvale, United States
pipelineangels.com
k4northwest.com
allianceofangels.com
Venture capital fund focused on underserved entrepreneurs is provided.
elevate.vcHillsboro, United States
An angel investment conference is organized in Bend, Oregon.
bendvc.comBend, United States
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
westcoastctip.org
willametteconference.com
clinicbyclevelandclinic.com
Premium access

Investor details for Hemex Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Hemexdx Private Limited (Hemex Health)

Hemexdx Private Limited is the primary company behind Hemex Health. The board of Hemexdx Private Limited currently have 4 directors; the longest-serving is Amrish Kantilal Mehta, appointed in 2018. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amrish Kantilal Mehta
DIN 07463167
Director30 May 20188 yrs 5 moHemexdx Private Limited
Patricia White Seminario
DIN 08146127
Director30 May 20188 yrs 5 moHemexdx Private Limited
Prashant Pramodrao Khadke
DIN 02622405
Managing Director09 Jun 20233 yrs 5 moHemexdx Private Limited
Suhas Suresh Tamras
DIN 11212131
Nominee Director13 Aug 20251 yr 3 moHemexdx Private Limited

People of Hemex Health

23 people are tracked at Hemex Health (16 in leadership, 7 in team); the tracked headcount is 1.

NameRoleGroup
Patti White
CEOLeadership
Peter Galen
Chief Innovation OfficerLeadership
David Bell
Chief Medical OfficerLeadership
Mohan Uttarwar
Founding Director, HemexDxLeadership
Poornima Kumar
Managing Director, HemexdxLeadership
Alireza Nasiri Avanaki
Chief Scientist, AlgorithmsLeadership
Brian Grimberg
Chief Scientist, MalariaLeadership
VP, Commercial Operations, HemexdxLeadership
Daren Bledsoe
VP, EngineeringLeadership
Gerrit J. van Roekel
VP, Business DevelopmentLeadership
Sulatha Dwarakanath
VP Of Assay Product DevelopmentLeadership
Priya Thota M.D. (Healthcare Mgmt)
Director Of Clinical Research And OperationsLeadership
J. Daren Bledsoe
Senior Vice President Of Engineering And OperationsLeadership
Sagar Parab
Deputy General ManagerLeadership
Tyler Witte
Director Of Research And DevelopmentLeadership
Umut Gurkan
Chief Scientist, MicrofabricationLeadership
Anurag Sharma
Growth ManagerTeam
Yiyang Fei
Software EngineerTeam
Joel Levenson
Industrial Design/ Prototype EngineerTeam
Shabbir Najmi
Manager- Field Application & SupportTeam

3 more people are available in the full profile.

Premium access

Complete people profiles for Hemex Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Hemex Health

Figures of Hemexdx Private Limited, the primary company behind Hemex Health, for FY 2025. Revenue was ₹30.36 Cr (+16% year on year). Net loss was -₹5.45 Cr (-18% margin). EBITDA was -₹5.35 Cr (-18% margin). Revenue has grown at a compounded annual rate of +52% over three years.

  • ₹30.36 CrRevenue · FY 2025 · +16% YoY
  • -₹5.45 CrNet loss · -18% margin
  • -₹5.35 CrEBITDA · -18% margin
  • ₹2 LakhPaid-up capital
  • 36Employees (provident fund records)
  • +52%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Hemexdx Private Limited are on its company page.

Premium access

Detailed financial statements for Hemex Health

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Hemex Health

3 dated milestones of Hemex Health across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Hemex Health is founded.
  2. Funding First funding round of $50K.
  3. Funding Latest funding round, Grant, of $332K.

Competitors of Hemex Health

Hemex Health has 3 listed competitors in our database, 1 of them funded. They include BioMedomics, Silver Lake Research Corporation and Halcyon Biomedical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biomedomics.com2006Durham, United States$1.5M14
Point-of-care diagnostic systems for blood-based disorders are developed.
silverlakeresearch.com1993United States32
Custom antibodies and diagnostics are developed for various applications.
halcyonbiomedical.com2013Friendswood, United States
Diagnostic solutions for hematological disorders
Premium access

Detailed competitors of Hemex Health

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Hemex Health

The website of Hemex Health (hemexhealth.com) receives about 2.1K visits a month.

  • Monthly visits
    2.1K

    ▼ 8.4% vs previous month

Top companies in Hematology

3 companies that operate in the same segment as Hemex Health (Hematology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Catheter-based thrombectomy devices for vascular emboli removal are developed.
2011Irvine, California, United StatesUSD 51.89 MUSD 493.63 M696
Small molecules are developed to treat hematologic and musculoskeletal disorders.
2016Lexington, Kentucky, United StatesUSD 90 MUSD 244.06 M169
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
2016Menlo Park, California, United StatesUSD 300 M384
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hemex Health

Premium access

Complete news archive for Hemex Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemex Health

Hemex Health was founded in 2016.

Hemex Health is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Patti White is the CEO of Hemex Health, as recorded in our data.

Hemex Health is a funded company, having raised a total of $6.24M across 16 funding rounds to date. The company's 1st funding round was a Grant of $1.96M, raised on Oct 2016.

Hemex Health has 1 employees.

The primary company behind Hemex Health, Hemexdx Private Limited, reported revenue of β‚Ή30.36 Cr for FY 2025, up 16% year on year.

Hemex Health was founded in 2016 in Portland, United States, within the health technology sector. Medical devices for diagnosing tropical diseases are developed through the platform. Two products are currently under development: a magneto-optical device used for rapid detection of all malaria species and HemeChip, a miniaturized form of cellulose acetate electrophoresis applied in sickle cell anemia diagnosis. Operations focus on point-of-care solutions for global health challenges.

Hemex Health's top competitors include Silver Lake Research Corporation, BioMedomics and Halcyon Biomedical.

Hemex Health has 11 investors. Key investors include NIH, The Indus Entrepreneurs, CTIP, Pipeline Angels, and Keiretsu Forum Seattle.

Hemex Health operates through Hemexdx Private Limited.

The legal entities of Hemex Health currently have 4 directors, including Amrish Kantilal Mehta, Patricia White Seminario, Suhas Suresh Tamras and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available